Cell Cycle Priority Targets:
1. CDK4/6 (approved drugs: palbociclib)
2. p53 pathway reactivation
3. E2F transcription control
4. Checkpoint kinase inhibition
5. Cyclin degradation pathways

MAPK Priority Targets:
1. EGFR family receptors
2. RAS pathway intermediates
3. MEK/ERK cascade
4. PI3K/AKT/mTOR axis
5. Feedback regulation nodes
